The purpose of this study is to determine if a new drug treatment is effective for the treatment of symptoms of urinary incontinence.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
94
sublingual dosing, 1 drop 3 times a day
sublingual dosing,1 drop 3 times a day
Regional Clinical Research, Inc.
Endwell, New York, United States
Rochester Clinical Research
Rochester, New York, United States
PEAK Research, LLC
Upper Saint Clair, Pennsylvania, United States
Percentage of Participants With a Decrease in Leakage Events of 30% or More.
Incontinence events were recorded on a daily diary. Leaks were scored and tabulated for a daily score. These values were utilized to come up with total of leakage events during the double-blind treatment period.
Time frame: Change from baseline after 4 weeks of treatment.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.